| 0 (0%) | 09-27 09:29 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 34.47 | 1-year : | 40.26 |
| Resists | First : | 29.51 | Second : | 34.47 |
| Pivot price | 28.32 |
|||
| Supports | First : | 26.27 | Second : | 24.28 |
| MAs | MA(5) : | 28.93 |
MA(20) : | 27.88 |
| MA(100) : | 22.98 |
MA(250) : | 21.94 |
|
| MACD | MACD : | 1.2  |
Signal : | 1.2 |
| %K %D | K(14,3) : | 83.4 |
D(3) : | 87.9 |
| RSI | RSI(14): 70.4 |
|||
| 52-week | High : | 29.51 | Low : | 17.23 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ GMAB ] has closed below upper band by 14.5%. Bollinger Bands are 34.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 29.14 - 29.26 | 29.26 - 29.36 |
| Low: | 28.42 - 28.56 | 28.56 - 28.69 |
| Close: | 28.82 - 29.06 | 29.06 - 29.26 |
Sat, 27 Sep 2025
Genmab A/S (NASDAQ:GMAB) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Wed, 24 Sep 2025
Guggenheim Upgrades Genmab A (GMAB) - Nasdaq
Wed, 24 Sep 2025
GMAB: Guggenheim Upgrades Genmab's Rating to 'Buy' on September - GuruFocus
Wed, 24 Sep 2025
New Analyst Forecast: $GMAB Given $43.0 Price Target - Quiver Quantitative
Wed, 24 Sep 2025
Here's Why We Think Genmab (CPH:GMAB) Might Deserve Your Attention Today - simplywall.st
Wed, 24 Sep 2025
Genmab (GMAB) Ownership Update: Orbis Manages Over 5% Stake - GuruFocus
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 616 (M) |
| Shares Float | 61 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 10.1 (%) |
| Shares Short | 3,850 (K) |
| Shares Short P.Month | 3,590 (K) |
| EPS | 1.92 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 86.2 |
| Profit Margin | 37.5 % |
| Operating Margin | 38.9 % |
| Return on Assets (ttm) | 13.2 % |
| Return on Equity (ttm) | 28.1 % |
| Qtrly Rev. Growth | 18.7 % |
| Gross Profit (p.s.) | 5.6 |
| Sales Per Share | 5.92 |
| EBITDA (p.s.) | 2.16 |
| Qtrly Earnings Growth | 73.1 % |
| Operating Cash Flow | 1,130 (M) |
| Levered Free Cash Flow | 771 (M) |
| PE Ratio | 15.06 |
| PEG Ratio | 0 |
| Price to Book value | 0.33 |
| Price to Sales | 4.9 |
| Price to Cash Flow | 15.83 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|